市場調査レポート
商品コード
1347958
医療用マイクロコントローラの世界市場-2023年~2030年Global Medical Microcontroller Market - 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
医療用マイクロコントローラの世界市場-2023年~2030年 |
出版日: 2023年09月11日
発行: DataM Intelligence
ページ情報: 英文 202 Pages
納期: 約2営業日
|
医療用マイクロコントローラの世界市場は、2022年に275億米ドルに達し、2023~2030年の予測期間中にCAGR 10.8%で成長し、2030年には483億米ドルに達すると予測されています。
医療機器における医療用マイクロコントローラの用途の拡大が、予測期間における医療用マイクロコントローラの市場成長を後押ししました。近年、医療機器は小型化し、持ち運びが容易になったため、小型の医療用マイクロコントローラの需要が増加しています。医療用マイクロコントローラは、医療におけるデータ収集、通信、遠隔モニタリングを可能にするために必要とされています。
医療用マイクロコントローラは、患者固有のニーズや状態に適応する個別化医療機器において重要な役割を果たします。個別化医療に向けたトレンドの高まりには、個々の患者に合わせた治療が含まれます。IoT対応機器などの接続機能を備えた医療機器は、医療用マイクロコントローラにとって大きなビジネスチャンスとなります。
北米で急速に成長している医療産業は、予測期間における医療用マイクロコントローラ市場の成長を後押しします。先進医療技術協会のデータによると、米国は世界最大の医療機器市場であり、世界の医療技術市場の40%以上を占めています。AIと機械学習は医療業界で急速に普及しています。
主要企業の中には、この市場で新製品を発売したところもあります。例えば、2023年4月28日、米国のMicrochip Technology Inc.は、5つの新しい8ビットPICおよびAVR MCU製品ファミリーと60以上の新しいデバイスを市場に投入しました。新たに発売されたAVR MCUとPICは、他のチップとの通信が容易です。
マイクロコントローラは、1つの集積回路パッケージにROM、RAM、CPU、クロック回路、I/O回路を搭載したデバイスです。従来のマイクロプロセッサのように、動作に付随するサポートチップを必要としません。マイコンは、アナログ回路を置き換えることで、リミッタ、整流器、コンパレータ、積分器、微分器、対数増幅器、アクティブフィルタ、位相感応型復調器などの信号処理機能をソフトウェアで実行できるという利点があります。
例えば、PIC18-Q40ファミリは、PIC18ポートフォリオを大容量フラッシュメモリ、小型フットマークパッケージ、多目的アナログおよびデジタルCIPで低ピンカウントに拡張し、ポータブルでスペースに制約のある設計に対応するなど、主要な機能を提供するマイクロコントローラです。このツールは、遠隔医療や遠隔診療、ネブライザーやシリンジポンプに使用される医療機器に使用されます。米国病院協会の報告によると、米国の病院の約76%が遠隔医療を利用して、患者や開業医と遠隔接続しています。
マイクロコントローラを使用することで、ICパッケージの数が少なくなり、複雑さが軽減され、コストとスペースの利点が得られます。さらに、自己校正機能とエラー検出機能を備えているため、バイオメディカル機器の信頼性が向上します。マイクロコントローラは、ハードウェア設計と基板密度が低く、メンテナンスが低コストであるため、携帯用医療機器に多く使用されています。
医療機器の用途が拡大するにつれ、医療のさまざまな側面を強化するために技術や機器が活用されるようになっています。患者の遠隔モニタリングに対する需要の高まりは、医療用マイクロコントローラ市場の活性化に貢献しています。ピッツバーグ大学医療センター(University of Pittsburgh Medical Center)のデータによると、医療業界における高度な技術機器は、病院の再入院リスクを76%低減し、患者の満足度を90%以上維持しています。
医療業界における遠隔医療の革新と導入は、医療機器の需要を刺激しています。また、医療提供者やスタッフが使用する医療機器は、患者の健康状態や治療状況を遠隔で延々と監視します。さらに、さまざまな生体認証デバイスやウェアラブルデバイスが若者の注目を集め、日々の医療で使用されるようになり、医療機器業界に新たな波をもたらし、医療用マイクロコントローラの潜在的なビジネスチャンスを生み出しています。
例えば、ABB社によると、ウェアラブル医療機器市場はCAGR18%で成長し、2021年の1,158億米ドルから2028年には3,805億米ドルになると予想されています。この業界では、高い技術革新と競争力のあるライバルが存在するため、将来的に新製品の革新が進み、最終的には医療用マイクロコントローラにも危機が訪れると予想されています。マイクロコントローラ(MCU)は、幅広いポータブル医療機器製品で重要な役割を果たしています。
医療産業プロセスの自動化とインダストリー4.0の原則の導入が、マイクロコントローラの需要を促進しています。インダストリー4.0は、医療機器の高度な製造技術の統合に主眼を置いています。人工知能、ロボット工学、IoTにより、スマートな生産システムが構築されます。マイクロコントローラは、医療産業の監視と制御において重要な役割を果たします。
例えば、2019年3月、中国の医師は、2,000マイル離れた手術台で患者の脳に刺激装置を導入するために遠隔手術ツールを使用しました。医療用ロボットは、脳卒中やその他の神経疾患で部分麻痺を起こした患者を助けます。センサーとマイクロコントローラは、人間の状態を検査するためにロボットに使用されています。
一般的なマイクロコントローラに比べて医療用マイクロコントローラのコストが高いのは、医療用途に必要な厳しい要件、特殊な設計、法規制への準拠があるためです。医療用マイクロコントローラのコストに影響を与える要因には、設計開発、規制対応、品質管理、認証などがあります。医療用マイクロコントローラの設計には、信頼性、安全性、精度を高めるための特別なエンジニアリングが必要です。
医療用マイクロコントローラは、FDAやIEC 60601などの国際規格が定める厳しい規制基準に準拠しています。医療用マイクロコントローラの製造には、患者の安全を確保するための品質管理プロセスが必要です。これらの要因により、医療用マイクロコントローラは高コストです。例えば、PIC16F877Aのコストは6.72米ドル/1個、ATMEGA328Pのコストは4.98米ドル/1個、LPC1113FBD48のコストは2.24米ドル/1個です。
Global Medical Microcontrollers Market reached US$ 27.5 billion in 2022 and is expected to reach US$ 48.3 billion by 2030, growing with a CAGR of 10.8% during the forecast period 2023-2030.
An increase in the applications of medical microcontrollers in medical devices helped to boost the market growth of medical microcontrollers over the forecast period. In recent years medical devices become more compact and portable hence the demand for small medical microcontrollers is increasing. Medical microcontrollers are required due to enabling data collection, communication and remote monitoring in healthcare.
Medical microcontrollers play an important role in personalized medical devices that adapt to patients' specific needs and conditions. The rising trend towards personalized medicine involves tailoring treatments to individual patients. Medical devices with the connectivity features, such as IoT-enabled devices offers tremendous opportunity for medical microcontrollers.
The rapidly growing medical industry in North America helps to boost the market growth of the medical microcontroller market over the forecast period. According to the data given by the Advanced Medical Technology Association, U.S. is the largest medical device market in the world accounted over 40% of the global medtech market. AI and machine learning are rapidly using in the medical industry.
Some of the major key players launched new products in the market. For instance, on April 28, 2023, Microchip Technology Inc., a U.S.-based company launched 5 new 8-bit PIC and AVR MCUs product families and over 60 new devices in the market. The newly launched products AVR MCUs and PIC are easily communicate with other chips.
Microcontrollers are a device that contains ROM, RAM, CPU, clock circuit and I/O circuity on a single integrated circuit package. It does not need accompanying support chips for its operation similar to conventional microprocessors. Microcontrollers have the advantage of performing the signal processing functions of a limiter, rectifier, comparator, integrator, differentiator, logarithmic amplifier, active filter and phase-sensitive demodulator in software by replacing analog circuits.
For instance, the PIC18-Q40 family is a microcontroller that offers key features including extending the PIC18 portfolio to low pin count with large flash memory, small footmark packages and multipurpose analog and digital CIPs for portable and space-constrained designs. The tool is used in medical devices used in telehealth and remote medical care, nebulizers and syringe pumps. As per the American Hospital Association reports, around 76% of U.S. hospitals use telehealth to connect remotely with patients and practitioners.
Using the microcontroller results in fewer IC packages which complexity reduces and provides cost and space benefits. Furthermore, It has the ability to self-calibration and detection of errors increasing the reliability of the biomedical instrument. Due to microcontrollers having diminished hardware design & board density and low-cost maintenance, they are mostly used in portable medical equipment.
Raping increasing the applications of medical instrumentation involves utilizing technology and devices to enhance various aspects of healthcare. Rising demand for remote patient monitoring helps to boost the medical microcontrollers market. According to the data given by the University of Pittsburgh Medical Center, advanced technological instruments in the medical industry reduce the risk of hospital readmissions by 76% and held patient satisfaction scores over 90%.
The innovation and adoption of telemedicine in the healthcare industry have inspired the demand for medical devices. Also, the medical devices used by healthcare providers and staff to endlessly monitor patient well-being and treatment situations remotely. Additionally, different biometric and wearable devices are gaining the attention of youths and becoming popular for use in day-to-day healthcare, providing a boost to a new wave of the medical devices industry and creating potential business opportunities for medical microcontroller
For instance, according to ABB company, the wearable medical devices market is expected to grow by CAGR of 18%, from US$ 115.8 Billion in 2021 to 380.5 Billion by 2028. High innovation and competative rivalary in this industry expacted to innovate new products in future, which will eventually create deamnd for medical microcontrollers as well. As microcontrollers (MCUs) are playing important role in a wide range of portable medical instrumentation products.
The automation of medical industrial processes and the implementation of Industry 4.0 principles are driving the demand for microcontrollers. Industry 4.0 majorly focuses on the integration of advanced manufacturing technologies of medical devices. Artificial intelligence, robotics and IoT create smart production systems. Microcontrollers play an important role in monitoring and controlling the healthcare industry.
For instance, in March 2019 Doctors in China used remote surgical tools for the implementation of stimulation devices in the patient's brain on an operating table that is 2,000 miles away. Healthcare robots help patients who have suffered partial paralysis due to stroke and other neurological conditions. Sensors and microcontrollers are used in the robots to examine human condition.
The higher cost of medical microcontrollers compared to standard microcontrollers is due to the stringent requirements, specialized design and regulatory compliance needed for the medical applications. Some of the factors affecting on the cost of medical microcontrollers are Design and Development, Regulatory Compliance, Quality Control and Certifications. Designing medical microcontrollers required extra engineering efforts for reliability, safety and accuracy.
Medical microcontrollers adhere to strict regulatory standards set by FDA and international standards like IEC 60601. The production of medical microcontrollers requires quality control processes for patients safety. Due to these factors medical microcontrollers have high cost. For instance, PIC16F877A has cost of US$ 6.72/1 pc, ATMEGA328P has cost of US$ 4.98/1 pc and LPC1113FBD48 has cost of US$ 2.24/1pc.
The global medical microcontrollers market is segmented based on type, application and region.
During forecast period 2022-2030, 16-bit microcontrollers is expected to dominate the global market with around 1/3rd share. Increase in the application of 16-Bit Microcontroller due to its low cost and power consumption. It gives higher processing power compared to 8-bit microcontrollers. The 16-Bit microcontroller is able to handle data manipulation, more complex algorithms and multitasking, which makes it suitable for moderate computational power applications.
The larger memory space of the 16-bit microcontrollers allows it for more extensive code storage. Also, an increase in product launches by major key players helps to boost segment growth over the forecast period. For instance, on October 16, 2021, Renesas Electronics Corporation, a supplier of advanced semiconductor solutions announced the launch of a 16-bit general-purpose RL78/G23 microcontroller. The new product launch further strengthens its RL78 Family of 8-bit and 16-bit MCUs for various applications.
North America medical microcontrollers market accounted largest market share of about 32.1% in 2022, due to the rapid growth in the medical devices industry. Due to this increase in the adoption and sales of medical microcontrollers. The rapid advancement in the patient monitoring devices, diagnostic equipment and implantable devices drives the need for high-performance microcontrollers with its advance features.
Due to the growing aging population in North America increase the demand of medical devices that aid in treatment, diagnostics and monitoring. The trend drives the demand for advanced microcontroller technology. According to the data given by U.S. Sensus Bureau, U.S.'s population age 65 and over grow nearly 5 times faster than the total population from 1920 to 2020. The older population in the region reached 55.8 million in U.S.
The major global players include: NXP Semiconductors, Renesas Electronics, Microchip Technology, Infineon Technologies, STMicroelectronics , Texas Instruments, GIE Media, Inc., Silicon Laboratories , Microchip Technology Inc. and Silicon Laboratories.
The COVID-19 pandemic has had a significant impact on economies and industries worldwide, including the medical microcontroller market. Medical microcontrollers are crucial components used in various electronic devices and systems. The outbreak of COVID-19 led to disruptions in global supply chains, affecting the production and availability of medical microcontrollers.
Lockdown measures, travel restrictions and factory closures implemented to contain the virus severely impacted the manufacturing and distribution processes. According to the International Monetary Fund (IMF), the global economy experienced a contraction of 3.5% in 2020 due to the pandemic.
Globally consumers are spending more time at home due to this there is increased demand for medical instruments. Rapid innovation in medical technology during the pandemic due to the urgent requirement of the patients. The market is negatively impacted due to disruptions in the supply chain, transportation restrictions and manufacturing challenges affecting the availability of components and materials used in medical microcontroller production.
The Russia-Ukraine conflict led to raw material shortages of medical microcontrollers due to the supply chain disruption which negatively impacted on the market growth. Ukraine is one of the major suppliers of raw materials used in medical microcontrollers manufacturing. Due to the disruption in supply chains raw materials required for medical microcontroller has been limited.
The shortage of raw materials has resulted in increased costs of medical microcontroller manufacturers. Ukraine, specifically, has a significant presence in the medical microcontroller industry, with several prominent semiconductor companies located within its borders. The conflict has led to disruptions in production and distribution channels, resulting in reduced availability of medical microcontrollers.
The ongoing conflict affected negatively on the medical microcontrollers market due to the supply chain disruptions and importand export restrictions. Due to this there is shortage of microcontrollers or components required for medical device manufacturing. Russia Ukraine affected zones facing challenges in the research and development of medical microcontroller. Due to the economic instability and uncertainty market is affected negatively due to the lack of funding and investments.
The global medical microcontrollers market report would provide approximately 53 tables, 47 figures and 202 pages.
LIST NOT EXHAUSTIVE